Clinical Trial Update: The Study is to Evaluate the Safety and Tolerability of SPGL008 Alone or in Combination With BCG in the Patients With NMIBC, and to Determine the RP2D of SPGL008 Alone or in Combination With BCG.To Evaluate the Preliminary Efficacy of SPGL008 Alone or in Combination With BCG. [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating SPGL008 alone or with BCG for non-muscle invasive bladder cancer to assess safety, determine the RP2D, and explore preliminary effi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• Bacillus Calmette-Guérin (Bacillus Calmette-Guérin)
• SPGL008

Snippet

Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD. | Conditions: NMIBC | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING